Induction of interleukin-4 and interleukin-5 expression in mast cells is inhibited by glucocorticoids

Clinical and Diagnostic Laboratory Immunology

Volumn 5, Issue 1, 1998, Pages 18-23

  Sewell, William A ^a,b   Scurr, Lyndee L ^a   Orphanides, Helen ^a   Kinder, Simon ^a   Ludowyke, Russell I ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b ST VINCENT S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID; INTERLEUKIN 4; INTERLEUKIN 5;

ALLERGY; ANIMAL CELL; ARTICLE; ASTHMA; CORTICOSTEROID THERAPY; DRUG EFFECT; DRUG EFFICACY; DRUG USE; EOSINOPHIL; MAST CELL; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0031883096     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/cdli.5.1.18-23.1998     Document Type: Article

References (44)

1. Auphan, N., J. A. DiDonato, C. Rosette, A. Helmberg, and M. Karin. 1995. lmmunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis. Science 270:286-290.
2. Barnes, P. J. 1993. Anti-inflammatory therapy for asthma. Annu. Rev. Med. 44:229-242.
3. Borger, P., H. F. Kauffman, D. S. Postma, and E. Vellenga. 1996. IL-7 differentially modulates the expression of IFN-gamma and IL-4 in activated human T lymphocytes hy transcriptioiial and posttranscriptinnal mechanisms. J. Immunnl. 156:1333-1338.
4. Boumpas, D. T., E. D. Anastassiou, S. A. Older, G. C. Tsokos, D. L. Nelson, and J. E. Balow. 1991. Dexamethasone inhibits human interleukin 2 hut not intcrleukin 2 receptor gene expression in vitro at the level of nuclear transcription. J. Clin. Invest. 87:1739-1747.
5. Braat, M. C., B. Oosterhuis, R. P. Koopmans, J. M. Meewis, and C. J. Van Boxtel. 1992. Kinetic-dynamic modeling of lymphocytopenia induced by the comhined action of dexamethasone and hydrocortisone in humans, after inhalation and intravenous administration of dexamethasone. J. Pharmacol. Exp. Ther. 262:509-515.
6. Bradding, P., J. A. Roberts, K. M. Britten, S. Montefort, R. Djukanovic, R. Mueller, C. H. Heusser, P. H. Howarlh, and S. T. Holgate. 1994 Interleukin-4. -5, and -6 and tumor necrosis factor-alpha in normal and asthmatic airways: evidence for the human mast cell as a source of these cytokines. Am. J. Respir. Cell Mol. Biol. 10:471-180.
7. Byron, K. A., G. Varigos, and A. Wootton. 1992. Hydrocortisone inhibition of human interleukin-4. Immunology 77:624-626.
8. Chomezynski, P., and N. Sacchi. 1987. Single step method of RNA isolation hy acid guanidinium thiocyanale-phenol-chloroform extraction. Anal. Biochem. 162:156-159.
9. Collado-Eseobar, D., J. R. Cunha-Melo, and M. A. Beaven. 1990. Treatment with dexamethasone down-regulates IgE-receplor-mediated signals and upregulates adenosine-receptor-mediated signals in a rat mast cell (RBE-2H3) line. .J. Immunol. 144:244-250.
10. Daynes, H.A., and B. A. Araneo. 1989. Contrasting effects of glucocorticoids on the capacity of T cells to produce the growth factors interleukin 2 and interleukin 4. Eur. J. Immunol. 19:2319-2.325.
11. Derendorf, H., H. Mollmann, J. Barth, C. Mollmann, S. Tunn, and M. Krieg. 1991. Pharmacokinetics and oral bioavailabitity of hydrocortisone. J. Clin. Pharmacol 31:473-476.
12. Foster, P. S., S. P. Hogan, A. J. Ramsay, K. I. Matthaei, and I. G. Young. 1996. Interleukin 5 deficiency abolishes eosinophilia, airways hyperrcaetivity, and lung damage in a mouse asthma model. J. Exp. Med. 183:195-201.
13. Galli, S. J. 1993. New concepts about the mast cell. N. Engl. J. Med. 328:257-265.
14. Glaum, M. C., .J. S. Jaffe, D. H. Gillespie, D. G. Raible. T. J. Post, Y. Wang, E. Dimitry, and E. S. Schulman. 1995. IgE-dependent expression of interlcukin-5 mRNA and protein in human lung: modulation by dexamethasone. Clin. Immunol. Imniunopathol. 75:171-178.
15. Hamid, Q., M. Azzawi, S. Ying, R. Moqbel, A. J. Wardlaw, C. .J. Corrigan, B. Bradley, S. R. Durham, J. V. Collins, P. K. Jeffrey, D. J. Quint, and A. B. Kay. 1991. Expression of mRNA for interlcukin-5 in mucosal bronchial biopsies from asthma. J. Clin. Invest. 87:1541-1546.
16. Jonat, C., 11. J. Rahmsdorf, K. K. Park, A. C. B. Cato, S. Gebel, H. Ponta, and P. Herrlich. 1990. Antitumour promotion and antiinflammation: down modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone. Cell 62: 1189-1204.
17. Kuhn, R., K. Rajewsky, and W. Muller. 1991. Generation and analysis of interleukin-4 deficient mice. Science 254:707-710.
18. Leal-Berumen, I., P. Conlon, and J. S. Marshall. 1994. IL-6 production by rat peritoneal mast cells is not necessarily preceded hy histamine release and can he induced by bacterial lipopolysaecharide. J. Immunol. 152:5468 -5476.
19. Lippert, U., P. Welker, S. Kruger-Krasagakes, A. Moller, and B. M. llenz. 1996. Modulation of in vitro cytokine release from human leukcmic mast cells (HMC-1) by glucocorticoids. Skin Pharmacol. 9:93-98.
20. Ludowyke, R. I., L. L. Scurr, and C. M. McNally. 1996. Calcium ionophore-induced secretion from mast cells correlates with myosin light chain phosphorylation by protein kinase C. J. Immunol. 157:5130-5138.
21. Maeyama, K., R. J. Hohman, H. Metzger, and M. A. Beaven. 1986. Quantitative relationships between aggregation of IgE receptors, generation of intracellular signals, and histamine secretion in rat basophillc leukemia (2H3) cells. Enhanced responses with heavy water. .J. Biol. Chem. 261:2583-2592.
22. + T cells. Eur. J. Immunol. 21:1187-1194.
23. Mu, H.-H., and W. A. Sewell. 1993. Enhancement of interleukin-4 production by pertussis toxin. Infect. Immun. 61:2834-2840.
24. Naora, ll., and I. G. Young. 1995. Comparison of the mechanisms regulating IL-5. IL-4, and three other lymphokine genes in the Th2 clone D10.G4.1. Exp. Hematol. 23:597-602.
25. Nudel, U., R. Zakut, M. Shani. S. Neuman, Z. Levy. and D. Yaffe. 1983. The nucleotide sequence of the rat cytoplasmic beta-actin gene. Nucleic Acids Res. 11:1759-1771.
26. 2- and purified isozymes in washed permeabilized cells. J Biol. Chem. 268:1749-1756.
27. Ramirez, F., D. .J. Fowell, M. Puklavec, S. Simmonds, and D. Mason. 1996 Glucocorticoids promote a Th2 cytokine response by CD4( + ) T cells in vitro. J. Immunol. 156:2406-2412.
28. Rolfe. F. G., J. M. Hughes, C. L. Armour, and W. A. Sewell. 1992. Inhibition of intcrlcukin-5 gene expression by dexamethasone. Immunology 77:494-499.
29. Rolfe, F. G., and W. A. Sewell. 1997. Analysis of human interleukin-5 gene transcription by a novel nuclear run on method based on the polymerase chain reaction. J. Immunol. Methods 202:143-151.
30. Rolfe, F. G., and W. A. Sewell. Unpublished data.
31. Rothenberg. M. E., A. D. Luster, and P. Leder. 1995. Murine eotaxin: an eosinophil cbcmoattraclant inducible in endothelial cells and in interlcukin 4-induccd tumor suppression. Proc. Natl. Acad. Sci. USA 92:8960-8964.
32. Sanderson, C. J. 1992. Interlcukin-5, eosinophils, and disease. Blood 79: 3101-3109.
33. Scheinman, R. I., P. C. Cogswell, A. K. Lofquist, and A. S. Baldwin, Jr. 1995. Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids. Science 270:283-286.
34. Schleimer, R. P., S. A. Sterbinsky, J. Kaiser, C. A. Bickel, D. A. Klunk, K. Tomioka, W. Newman, F. W. Luscinskas, M. J. Gimbrane, B. W. Mclntyre, et al. 1992. IL-4 induces adherence of human eosinophils and basophils but not neutrophils to endothelium. Association with expression of VCAM-1. J. Immunol. 148:1086-1092.
35. Seldin, D. C, S. Adelman, K. F. Austen, R. L. Stevens, A. Hein, J. P. Caulfield, and R. G. Woodbury. 1985. Homology of the rat basophilic leukemia cell and the rat mucosal mast cell. Proc. Natl. Acad. Sci. USA 82: 3871-3875.
36. Tepper, R. I., D. A. Levinson, B. Z. Stanger, J. Campos-Torres, A. K. Abbas, and P. Leder. 1990. IL-4 induces allergie-like inflammatory disease and alters T cell development in lransgenic mice. Cell 62:457-467.
37. Uberla, K., W. Q. Li, Z. H. Qin. G. Riehter, T. Raabe, T. Diamantstein, and T. Blankenstein. 1991. The rat intcrlcukin-5 gene: characterization and expression by retroviral gene transfer and polymerase chain reaction. Cytokine 3:72-81.
38. Valentine, J. E., M. J. Boyle, N. M. Gough, and W. A. Sewell. 1992. Presence of single-stranded DNA in PCR products of slow electrophoretic mobility. BioTechniques 13:222-224.
39. Warbrick, E. V., A. L. Thomas, and C. M. M. Williams. 1997. The effects of cyclosporin A, dexamelhasone and other immunornodulatory drugs on induced expression of IL-3, IL-4 and TL-8 mRNA in a human mast cell line. Toxicology 116:211-218.
40. Wershil, B. K., G. T. Furuta, J. A. Lavigne, A. R. Choudhury, Z. S. Wang. and S. J. Galli. 1995. Dexamethasone or cyclosporin A suppress mast cellleukocyte cytokine cascades. Multiple mechanisms of inhibition of IgE-and mast cell-dependent cutaneous inflammation in the mouse. J. Immunol. 154:1391-1398.
41. White, M. V., Y. Igarashi, J. D. Lundgren, J. Shelhamer, and M. Kaliner. 1991. Hydrocortisone inhibits rat basophilic leukemia cell mediator release induced by neutrophil-derived histamine releasing activity as well as by anli-IgE. J. Immunol. 147:667-673.
42. Williams, C. M. M., and J. W. Coleman. 1995. Induced expression of mRNA for IL-5, IL-6. TNF-α, MIP-2 and IFN-γ in immunologically activated rat peritoneal mast cells: inhibition by dexamethasone and cyclosporin A. Immunology 86:244-249.
43. Wu, C. Y., C. Fargeas, T. Nakajima, and G. Delespesse. 1991. Glucocorticoids suppress the production of interleukin 4 by human lymphocytes, Eur. J. Immunol. 21:2645-2647.
44. Ying, S., S. R. Durham, C. J. Corrigan, Q. Hamid, and A. B. Kay. 1995. Phenotype of cells expressing mRNA for Th2-Type (interleukin 4 and interleukin 5) and Th l-type (interleukin 2 and Interferon gamma) cytokines in bronchoalveolar lavage and bronchial biopsies from atopic asthmatic and normal control subjects. Am. J. Respir. Cell Mol. Biol. 12:477-487.